US Broker Ratings

Premier, Inc. (PINC) Investor Outlook: Navigating A Challenging Healthcare Landscape with a Strong Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a diverse array of solutions aimed at enhancing provider performance, optimizing supply chains, and fostering value-based care...

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring an 88.57% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $2.61 billion, this Stamford,..

Scholar Rock Holding Corp. (SRRK) Stock Analysis: Biotech Innovator with Strong Buy Signals

Scholar Rock Holding Corporation (NASDAQ: SRRK) is a notable player in the biotechnology sector, engaging in pioneering work to develop treatments targeting serious diseases influenced by protein growth factor signaling...

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 21% Upside Potential

Warby Parker Inc. (NYSE: WRBY) stands out in the healthcare sector with its innovative approach to eyewear retail. As a prominent player in the medical instruments and supplies industry, the..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 32% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a standout player in the dynamic biotechnology sector, offering a diverse portfolio of licensed biopharmaceutical assets. Based in Jupiter, Florida, Ligand is a significant..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 60% Potential Upside in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) has been catching the attention of investors with its promising 60.07% potential upside, according to recent analyst ratings. Specializing in Medicare Advantage plans across..

Concentra Group Holdings (CON): Analyst Ratings Signal 21% Upside in Healthcare Stock

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) offers an intriguing proposition. Headquartered in Addison, Texas, Concentra has carved out a significant niche in the..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook with a 99% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech firm focused on pioneering treatments for rare endocrine diseases, is capturing the attention of savvy investors with a staggering potential upside of..

Addus HomeCare Corporation (ADUS) Stock Analysis: 23.9% Upside Potential Makes It a Compelling Buy

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing investor attention with its robust growth trajectory and promising analyst ratings. The company, headquartered in Frisco,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Evaluating a 25% Upside Potential in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline and notable potential for growth. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Potential 75% Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a market capitalization of $2.93 billion, focusing on developing therapeutics for neurodegenerative and lysosomal storage diseases. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a Potential 33% Upside for Investors

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers a compelling opportunity for investors seeking growth in the innovative field of..

Alvotech (ALVO): A 378% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, presents a compelling investment opportunity with a staggering 377.73% potential upside according..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generic Drug Market

Investors with an eye on the healthcare sector might find Amneal Pharmaceuticals, Inc. (AMRX) a compelling prospect, especially as the company makes significant strides in the competitive landscape of generic..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Potential in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista has carved a niche..

QuidelOrtho Corporation (QDEL): Analyzing Its 47% Potential Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company delivers diagnostic testing solutions that..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 27% Upside Potential in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with a market cap of $5.58 billion and a focus on developing treatments for rare disorders. As the company..

ImmunityBio, Inc. (IBRX)

⚠️ No article content returned.

..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 190% Potential Upside Awaits Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering biopharmaceutical company, stands at the forefront of developing therapies for rare and ultra-rare genetic diseases. Based in Novato, California, the company is renowned..

Surgery Partners, Inc. (SGRY) Stock Analysis: Is the 64.65% Upside Potential Within Reach?

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a notable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2 billion, this Brentwood,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds